Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 4/20 | 0.56 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.53 |
| ▸ | POLB | P06746 | 1/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.48 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.44 |
| ▸ | SCN5A | Q14524 | 1/20 | 0.44 |
| ▸ | SCN3A | Q9NY46 | 1/20 | 0.44 |
| ▸ | NPC1 | O15118 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 3/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.43 |
| ▸ | USP30 | Q70CQ3 | 1/20 | 0.42 |
| ▸ | SCN4A | P35499 | 1/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.39 |
| ▸ | JAK2 | O60674 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7551114 | 0.87 | KMT2A (0.58) | KMT2ASMN1; SMN2POLB | |
| SCHEMBL7146326 | 0.87 | KMT2A (0.58) | KMT2ASMN1; SMN2POLB | |
| SCHEMBL30487448 | 0.87 | KMT2A (0.73) | KMT2ASMN1; SMN2POLBALDH1A1LMNA | |
| SCHEMBL30689138 | 0.84 | KMT2A (0.54) | KMT2ASMN1; SMN2POLBALDH1A1LMNA | |
| SCHEMBL11111706 | 0.83 | SMN1; SMN2 (0.57) | KMT2ASMN1; SMN2POLBALDH1A1LMNA | |
| SCHEMBL30487494 | 0.83 | CMA1 (0.54) | KMT2ASMN1; SMN2POLBALDH1A1MEN1 | |
| SCHEMBL26388634 | 0.81 | CYP3A4 (0.38) | KMT2AALDH1A1MEN1 | |
| SCHEMBL31124686 | 0.81 | KMT2A (0.61) | KMT2ASMN1; SMN2POLBALDH1A1LMNA | |
| SCHEMBL7152157 | 0.80 | KMT2A (0.68) | KMT2ASMN1; SMN2POLBALDH1A1LMNA | |
| SCHEMBL7550451 | 0.80 | KMT2A (0.68) | KMT2ASMN1; SMN2POLBALDH1A1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230312643-A1 | PEPTIDE DERIVATIVE WITH COLLAGENASE INHIBITORY ACTIVITY, AND USE THEREOF | SUNMARINE BIOTECH (KR) | 2023-10-05 | — | — | US | disclosed |
| WO-2022055045-A1 | PEPTIDE DERIVATIVE WITH COLLAGENASE INHIBITORY ACTIVITY, AND USE THEREOF | 주식회사 선마린바이오테크 | 2022-03-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230312643-A1 | PEPTIDE DERIVATIVE WITH COLLAGENASE INHIBITORY ACTIVITY, AND USE THEREOF | MMP1, MMP2, MMP13 | KMT2A 4655/4885SMN1; SMN2 3150/4885POLB 921/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.